[{"Assets_0_Q1_USD":1529104000.0,"CommonStockSharesConverted_0_Q1_shares":55620000.0,"CommonStockSharesOutstanding_0_Q1_shares":55620000.0,"EarningsPerShareBasic_1_Q1_USD":-3.64,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-206121000.0,"NetIncomeLossConverted_1_Q1_USD":-202611000.0,"RevenuesConverted_1_Q1_USD":21863000.0,"StockholdersEquity_0_Q1_USD":1120433000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]